ABSTRACT Sarcolemma damage and activation of various calcium channels are implicated in altered Ca 2+ homeostasis in muscle fibres of both Duchenne muscular dystrophy (DMD) sufferers and in the mdx mouse model of DMD. Previously we have demonstrated that also in mdx myoblasts extracellular nucleotides trigger elevated cytoplasmic Ca 2+ concentrations due to alterations of both ionotropic and metabotropic purinergic receptors. Here we extend these findings to show that the mdx mutation is associated with enhanced store-operated calcium entry (SOCE). Substantially increased rate of SOCE in mdx myoblasts in comparison to that in control cells correlated with significantly elevated STIM1 protein levels. These results reveal that mutation in the dystophin-encoding Dmd gene may significantly impact cellular calcium response to metabotropic stimulation involving depletion of the intracellular calcium stores followed by activation of the store-operated calcium entry, as early as in undifferentiated myoblasts. These data are in agreement with the increasing number of reports showing that the dystrophic pathology resulting from dystrophin mutations may be developmentally regulated.
4
The mdx mouse and dystrophin-positive C57Bl10 myoblast cell lines were used. These two cell lines were derived from the "immorto mouse" or H2Kb-tsA58 line [14] and tested for their muscle phenotype and for myogenic potential following differentiation [5, 15, 16,] . Cells were cultured in Dulbecco's modified Eagles' medium (DMEM) supplemented with 20% foetal calf serum (FCS), 4 mM L-glutamine, 100 unit/ml penicillin, 100 g/ml streptomycin, and 20 unit/ml murine -interferon (Invitrogen, San Diego, CA,USA) at 33°C in a 95% air, 5% CO2 atmosphere. When the cells reached 95% of confluence their myogenic properties could be confirmed by their ability to differentiation into myotubes. It was induced by changing the growth medium to the differentiation one containing 2% horse serum (HS) instead of FCS and depleted of -interferon and incubation at 37°C. Myotubes were examined after 3-6 days in culture. All media and reagents were purchased from Sigma (Poole, UK).
Primary myoblast culture
Mice were used with the approval of the local ethics commission (Polish Law on the Protection of Animals). Satellite cells were prepared from hindlimb muscle of control (C57BL/10ScSnJ) and dystrophic (C57BL/10ScSn-Dmd<mdx>/J) adult (2-3 month-old) male mice (Jackson Laboratory, Jacksonville, USA). Isolation and purification of satellite cells from tibialis anterior (TA) and soleus (Sol) muscles and myoblast culture procedures were performed as described in [17] . Briefly, whole muscles were sterilized in PBS with betadine and iodine and then digested with 0.2% collagenase type I in DMEM for 1.5 h at 37°C, rinsed in DMEM supplemented with 1 g/l glucose, 1 mM pyruvate, 4 mM L-glutamine, 10% HS, 0.5% chicken embryo extract (CEE), 1000 U/l penicillin (1000 U/l) and 1 mg/l streptomycin and triturated with pipettes of gradually decreasing diameter.
Entire fibres were separated, rinsed four times with the same medium and finally transferred into DMEM (composition as above, supplemented with 20% FBS). Purified fibres were dispersed by forcing through an 18 guage injection needle, filtered through 40 m pore diameter nylon bolting cloth, put into collagen-coated culture dishes and incubated in the same medium at 37°C in humidified atmosphere of air (95%) and CO2 (5%) for 5 days.
RT-PCR analysis
Total cellular RNA was extracted from myoblasts using RNA Isolation System (Promega, Southampton, UK) and 5 g of RNA were reverse transcribed using random hexamers and the Superscript First Strand Synthesis System (Fisher). Reverse transcriptase was omitted in negative control samples. RT-PCR was performed with primer sets specific for STIM1 transcripts: Fv: 5'-TGCTGTTTGGGCCTCCTCTC-3' and Rev: 5'-CCTCCACCTCATGGGTCAGC-3' based on [18] .
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PCR conditions for amplification were 94°C for 4 min, followed by 35 cycles of 94°C for 60 s, 58°-60 o C for 60 s, 72°C for 60 s with a final extension step of 72°C for 7 min. The identity of the amplicons was confirmed by sequencing and restriction analysis. Semi-quantitative analyses of STIM1 expression were performed essentially as previously described [5] . All experiments were repeated at least 3 times and performed in triplicate.
Protein extraction and analysis
Proteins were extracted from adherent cells by scraping into extraction buffer (1x LysisM, 1x
protease inhibitor cocktail, 2 x phosphatase inhibitor cocktail (all Roche), 2 mM sodium orthovanadate (Sigma) suspending with the use of automatic pipets and incubation of this suspension on ice for 20 min. After centrifugation (15 000 x g, for 20 min at 4 o C) protein concentrations in supernatants collected were determined using a bicinchoninic acid assay kit (Sigma). Remaining supernatants were mixed with sample buffer at 3:1 v /v ratio, heated for 5 min at 95 C and chilled on ice and stored at -80 o C. Proteins were separated on SDS-polyacrylamide gels (6-12% w /v depending on the molecular mass of protein) and electroblotted onto Hybond C membranes (Amersham, UK).
Blots were blocked in 5% w /v non-fat milk powder in 1x TBST, 0.01% v /v Tween-20 (Sigma) for 1h prior to probing with appropriate primary antibody (for STIM1, NCX, SERCA1 and 2 from Alomone, or TRPC1, TRPC3 and TRPC6 from Abcam) or diluted in a blocking buffer containing 2% milk (for 1h at RT) then washed (3x) with 1x PBST for 10 min and incubated with the appropriate horseradish peroxidase-conjugated secondary antibody (Sigma) for 1h. Specific protein bands were visualized using luminol-based substrates (Uptilight US, Cheshire Sciences) and images obtained using a G-BOXChemi XT-16 system (Syngene). -actin antibody (Sigma) was used as a protein-loading control. Densitometric analyses of specific protein bands were made using exposure times within the linear range and the integrated density measurement function of Image J software.
All experiments were repeated at least 3 times with similar results obtained in each replicate. Western data, and n=3-9 for other analyses. In the case of immortalised myoblasts "n" represents the number of independent experiments with cells derived from different passages. In the case of primary myoblasts it refers to the number of experiments with cells derived from different "n" animals (i.e. biological replicates).
Results

Myoblast calcium response to stimulation with nucleotides
We have analysed functional differences in store-operated calcium entry between wild-type (w/t) and dystrophic mouse myoblasts. These cells have been extensively characterized previously [5, 16,] and show myogenic characteristics upon differentiation (Fig 1) . Stimulation of myoblasts placed in the calcium-free buffered salt solution with 1 mM ATP resulted in an immediate increase in cytosolic Ca 2+ ( Fig. 2A) . This reflects calcium release from the intracellular stores, due to activation of a P2Y-evoked and protein G-mediated signalling pathway. More pronounced response in mdx myoblasts may suggest higher susceptibility of dystrophic cells to such an excitation than one shown by control myoblasts. Similar treatment of cells in the presence of extracellular Ca 2+ also causes more intensive increase in cytosolic Ca 2+ in mdx cells (Fig. 2B ). In this case, increase in the cytosolic Ca 2+ concentration may correspond not only to depletion of the ER stores but also to activated capacitive Ca 2+ entry into cells, secondary to the calcium release. Moreover, ATP could, at least potentially, activate Ca 2+ influx due to activation of ionotropic receptors belonging to the P2X family. However, as we have previously shown, the only functional receptor active in these cells being P2X7, it can be fully inhibited by CBB [4] . Thus, preincubation of cells with this inhibitor allowed selective Therefore, subsequent experiments were focused on this question.
Alteration of store operated mechanisms in dystrophic myoblasts
To answer this question, cells placed in the calcium-free solution were treated with thapsigargin to irreversibly inhibit SERCA and completely deplete intracellular calcium stores. After depletion of the ER calcium stores and establishment of the cytosolic Ca 2+ concentration at a stable level under calcium-free conditions, the assay medium was supplemented with 2 mM CaCl2. Such approach allowed skipping first steps of cell activation (comprising of receptor stimulation, PLC activation, and IP3 formation and Ca 2+ release from the stores) and permitted investigating calcium entry independently of any primary extracellular stimulus and receptor activation. Thapsigargin-evoked total depletion of the ER calcium stores results in maximal activation of SOCE. Changes of fluorescence measured using the Fura-2 probe allow estimating the rate of Ca 2+ entry seen as an initial slope of the curve representing increase in cytosolic Ca 2+ concentration immediately after the addition of CaCl2 into the assay. Using this approach we minimize any influence of other processes, which may affect an increase of cytosolic Ca 2+ concentration as a direct result of accelerated Ca 2+ entry As shown in Fig 3A and B we have found that Ca 2+ entry into mdx cells was substantially faster than into respective w/t myoblast. It should be emphasized that an addition of CaCl2 into the assay without preincubation of cells with thapsigargin was not followed by any Ca 2+ influx to either w/t or mdx myoblasts (not shown). This excludes unspecific Ca 2+ influx, which could affect thapsigargininduced store-operated calcium. Moreover, the maximal Ca 2+ concentration reached much higher levels in mdx then in control cells. However, this value may be strongly affected by processes lowering cytosolic Ca 2+ concentrations because it delimits a point of equilibrium between calcium influx into and efflux from a cell. In addition, a feed-back inhibition of store-operated calcium channels by Ca 2+ accumulated beneath the plasma membrane must be considered. Therefore, comparisons of the maximal values of calcium transients in control and dystrophic myoblasts do not seem to be a reliable measure of SOCE activity. This seems particularly remarkable in the view of 8 data shown in Fig. 3D indicating evidently enhanced levels of Na + /Ca 2+ exchanger (NCX), which is Fig. 3A ) has revealed that the half-time of recovery of the cytosolic Ca 2+ concentration to the new steady state is significantly shorter and that Ca 2+ is removed much faster in mdx then in w/t myoblasts (Fig. 4) .
Moreover, mdx and w/t myoblasts differ in their response to thapsigargin. As shown in Fig. 3A, faster increase of the cytosolic Ca 2+ concentration following addition of thapsigargin in mdx myoblasts may be correlated with significantly increased SERCA1 and SERCA2 protein levels ( Fig. 3E and F concentrations are strongly influenced by the process of calcium removal. One likely explanation for the observed difference concerning rate of calcium entry upon supplementation of the assay with CaCl2 could be that dystrophic cells exhibit more active SOCE due to higher levels of proteins crucially involved in this process. This possibility we studied using Western blotting analysis of major proteins participating in SOCE: STIM1 and Orai1. Furthermore, amounts of TRPC1, TRPC3
and TRPC6 (other proteins believed to participate in SOCE) were also tested in both w/t and mdx myoblasts. As shown in Fig. 5A , STIM1 protein levels in mdx myoblasts were substantially higher than it w/t cells. Similar phenomenon was observed at later stages of differentiation in healthy and dystrophic muscles [13] . On the other hand, semi-quantitative PCR assay has nor revealed any noticeable differences between the STIM1 transcript content in both cell lines used in this study (Fig.   5C ). We also found that the total level of Orai1 protein was the same in both cell lines tested (Fig. 6 ).
This observation is contrary to the data from differentiated muscle cells and indicate important differences in cellular calcium homeostasis during maturation of w/t and dystrophic muscles [13] .
Also amount of TRPC1 and TRPC3 proteins, which are postulated to be involved in abnormal Ca 2+ homeostasis in dystrophic adult muscle fibres [ 20, 21, 22] were unchanged or only insignificantly lowered in mdx myoblasts, while TRP6 protein content in dystrophic myoblasts was reduced 9 substantially (Fig. 6B) . In summary, these data suggest that, Orai1 and TRPC1, 3 and 6 proteins seem not responsible for stimulated Ca 2+ entry into mdx myoblasts, due to their unchanged or even reduced (TRPC6) expression in mdx myoblasts. However, an increased activity/altered distribution of these proteins despite their unaltered/reduced levels could not be definitely excluded.
To exclude cell-line specific effects, the experiments were repeated in a second set of immorto mdx and w/t cells (independently derived from different lines of H2Kb-tsA58 w/t and mdx mice) and the same responses were found.
Furthermore, to exclude the possibility that some of the effects were due to cell immortalization, primary myoblasts isolated from mdx and w/t tibialis anterior and soleus muscles were analysed to study the thapsigargin-induced Ca 2+ entry ( Fig. 6A and B) . Also in this case, significant up-regulation of SOCE correlated with increased levels of STIM1 protein in dystrophic myoblasts isolated from these two different muscle groups (Fig 6C) .Unfortunately, high fragility of the primary myoblasts even grown on specially coated surfaces, forced us to modify the assay in order to keep its time as short as possible following the addition of thapsigargin used for depletion of the ER calcium stores.
Nevertheless, differences between rates of Ca 2+ entry were evident irrespective of not always completely reaching a steady state prior to addition of CaCl2. Importantly, preincubation of myoblasts with 2-APB, commonly used inhibitor of SOCE [23] , abolished Ca 2+ entry into both wt and mdx cells isolated from tibialis anterior, thus finally confirming participation of SOCE in the observed Ca 2+ entry (data not shown). In summary, findings in primary muscle cells confirmed the aforementioned data in myoblast lines and ruled out the possibility that the up-regulation of SOCE in immortalized mdx myoblasts was an artefact of cell modifications.
Discussion
Paracrine or autocrine stimulation of muscle cells with ATP, which is released in small amounts in response to skeletal muscle physiological activity, modulates Ca 2+ homeostasis and muscle plasticity via activation of P2 receptors [24] . However, although first indications of the functional significance of ATP receptors in skeletal muscle cells emerged in 1983 [25] , our understanding of the roles of specific P2 receptors in this tissue started emerging only recently. It is beyond any doubts that Gqlinked nucleotide receptors are involved in muscle cell differentiation, regeneration and motility [26 27, 28, 29, 30 (and references cited herein)]. Interestingly, several P2 receptors were found differentially expressed in muscles at different stages of DMD pathology [30, 31] . Moreover, enhanced Ca 2+ entry into dystrophic myofibers due to activation of various Ca 2+ channels and transport mechanisms has been described repeatedly [13, 32] . Such abnormalities are believed to be a result of impaired scaffolding of membrane proteins involved in Ca 2+ signaling due to the absence of dystrophin-associated protein complexes [33] . These observations have been expanded by us and others showing that mutations in dystrophin gene closely correlate with alteration of ATP signaling and that this abnormality affects myoblasts [4, 5] and lymphoblasts [34] . While convincing identification of Gq-linked P2Y receptor(s) producing the ATP-evoked abnormal Ca 2+ increases in dystrophic myoblasts requires further studies, an enhanced metabotropic response to nucleotide stimulation is beyond any doubt.
We have found that the metabotropic purinergic response was significantly higher in dystrophic versus control cells both in the absence and in the presence of extracellular Ca 2+ but in the latter case the relative stimulatory effect was more pronounced (see Fig. 2 ). This observation indicated that mdx myoblasts are more susceptible not only to nucleotide-induced Ca 2+ release, but also that Ca 2+ influx from the extracellular milieu, secondary to the Ca 2+ release from the ER, is more effective in these cells. Undoubtedly however, SOCE participates in generation of abnormal calcium signals in dystrophic myoblasts exposed to multiple stimuli acting via depletion of the intracellular calcium stores.
Enhanced SOCE into muscle fibres with the mutated dystrophin gene has been described previously.
It was attributed to various mechanisms, including an impaired dystrophin/ 1-syntrophin scaffold formation [35] and increased STIM1 and Orai1 protein levels [13] . However, it must be stressed that these DMD studies were performed in differentiated muscle cells (myotubes and myofibers) and not in myoblasts used in our study, which are very different structurally and functionally.
Previously, we have shown that mitochondrial membrane potential in dystrophic cells is higher than in controls [36] . This could imply more efficient mitochondrial buffering of calcium ions which reduces a feedback inhibition of SOCE by Ca 2+ accumulated in the close vicinity of the calcium channels [37] . However, dissipating mitochondrial potential with protonophore (CCCP), although resulting in a substantial inhibition of SOCE, did not abolish the difference between w/t and dystrophic myoblasts (data not shown). It suggests that the cause of the observed difference lies elsewhere.
In this study, the overstimulation of SOCE in dystrophic cells has been correlated with the increased STIM1 protein content. This difference was observed both between immortalized and primary dystophic and control myoblasts, thus excluding potential side-effect of immortalization. Therefore, 11 the more effective SOCE in dystrophic myoblasts could, at least to some extent, depend on differences in the levels of this crucial store-operated Ca 2+ channel protein.
Interestingly, SOCE is of great importance in differentiating myoblasts and increasing levels of STIM1 correlate with accelerated muscle differentiation [38] . Consequently, it was shown that overexpression of STIM1 stimulates muscle cell differentiation, while silencing it inhibits this process [39] . Thus, it appears possible that the more active SOCE/higher STIM1 levels in dystrophic myoblasts reflect their higher "readiness" for differentiation described by others [40, 41] and also seen by us. Such over-activation of SOCE upon dystrophic cell stimulation might lead to cellular calcium overload and to increased susceptibility to cell death thus contributing to progressive muscle degeneration [43 (and references cited herein)].
It remains to be tested whether the elevated NCX content in dystrophic cells shown here is accompanied by its higher activity and reflects a defence mechanism protecting these cells against excessive calcium accumulation. If so, this mechanism could participate in cell adaptations enhancing their viability, as has been suggested elsewhere [42 (and references cited herein)]. In addition, substantially increased thapsigargin-induced SOCE rate in dystrophic mdx myoblasts could be underestimated because of the increased NCX levels in these cells.
Significantly elevated STIM1 protein level has also been found in situ, in fully differentiated dystrophic muscle fibres from the extensor digitorum longus muscle [13] . We have extended this observation by finding increased STIM1 levels in myoblasts of two other mouse leg muscles: soleus and tibialis anterior. These data show the same pattern of dystrophy-induced changes in both undifferentiated myoblasts and fully matured muscle cells. Conversely, dystrophin deficiency was also found to be accompanied by increased amount of Orai1, the second crucial protein involved in SOCE [13] while data shown here does not confirm this effect. It may suggest that a profile of changes concerning molecules involved in shaping the intracellular calcium homeostasis during muscle differentiations is strongly dependent on mutations in the dystrophin gene.
However, it must be stressed that while in differentiated muscle cells (myotubes and myofibers) the dystrophin protein presence was confirmed, in myoblasts used in our study, dystrophin protein is undetectable using standard Western blotting methods. Thus, an interpretation of the observed differences implying the impaired dystrophin-dependent scaffold formation seems to be unsatisfactory. Several experiments addressing this problem could be envisaged.
Considering the causative link between the disruption of the DAP complex or between DAP and its interacting proteins in dystrophic myotubes and the alteration of calcium homeostasis there, it has been
shown that over-expression of mini-or full-length dystrophin improved calcium handling in cultured myotubes [43, 44] . It would be interesting to test whether expression of such mini-genes in myoblasts reduces intensity of SOCE to the control level.
Data presented here contest the conventional belief that mutations in dystrophin-encoding gene do not affect undifferentiated muscle cells. In all the experiments in this study, wild type and dystrophic myoblasts were tested outside their respective muscle environments, following a period of culture in vitro and so all the observed differences must have an intrinsic origin. The only difference between these cells is the presence or absence of the fully-functional Dmd gene. Therefore, results presented here add to a set of data challenging the current belief that mutations in this dystrophin-encoding gene do not affect undifferentiated muscle cells but only differentiated myotubes and myofibres. In contrast with this dogma, several studies conducted by us and others showed that dystrophic myoblasts similarly as in the case of lymphoblasts differ from wild type cells [4, 5, 34, 45] . For example, mdx myoblasts have altered expression and function of P2X7 receptors, leading to abnormal Ca 2+ influx, ERK phosphorylation [4, 5] and triggering a unique mechanism of autophagic cell death [6] . Moreover, dystrophin knockdown in adult muscles did not produce any pathology indicating that early dystrophin expression is crucial [46] . Indeed, examination of myogenesis revealed that this pathology starts in embryonic development arising from the loss stem cell. Thus, dystrophin expression appears to be essential for emergent stem cell function(s) and it has been shown that its absence alters myoblast differentiation processes [47] and their energy homeostasis [36] DMD studies have been conducted using myotubes or myofibers, which reflected observations that while myoblasts contain dystrophin transcripts, these cells have little or any detectable protein [48, 49, 50] . Therefore, no phenotypic consequences of the protein absence due to mutations in the dystrophin gene were to be expected. Contrary to this, Ferrari et al., (1994) showed that DMD lymphoblasts (also expressing mRNA but with undetectable dystrophin protein levels) are more susceptible to ATP damage [34] , exactly as the dystrophic myoblasts are. It is currently not known whether these effects are mediated by the residual protein or dystrophin mRNA-dependent regulatory pathways: An interesting alternative to the structural/scaffolding role of a trace amounts of dystrophin protein could be that the dystrophin transcript, which is absent in mdx cells due to nonsense-mediated decay, plays an important regulatory role in myoblasts.
To conclude, data described hitherto indicate that mutation in the dystrophin-encoding gene results in multiple phenotypic alterations that extend beyond structural stability of muscle fibre sarcolemma and clearly can also demonstrate as early as in undifferentiated myoblasts. The increased SOCE due to enhanced STIM1 level together with purinergic abnormalities occurring in dystrophic myoblasts could affect muscle regeneration and thus exacerbate the disease phenotype. 
